Overview
Markus Feufel practices practicing medicine in Berlin, Germany.
His clinical expertise encompasses Ovarian Cancer, BRCA Positive Breast Cancer, and Breast Cancer.
He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Markus A. Feufel
Is Markus A. Feufel a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Markus A. Feufel is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Markus A. Feufel participate in research or clinical trials?
Yes. Markus A. Feufel has published 63 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Markus A. Feufel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BRCA Positive Breast CancerMr. Feufel isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast CancerMr. Feufel isExperienced. Learn about Breast Cancer.
- Ovarian CancerMr. Feufel isExperienced. Learn about Ovarian Cancer.